AU Patent

AU2011212561B2 — Medicated module with time lock

Assigned to Sanofi Aventis Deutschland GmbH · Expires 2014-11-20 · 11y expired

What this patent protects

A medicated module (4) for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device (7) containing a primary medicament accepts a medicated module (4) containing a single dose of a second medicament (2) and where both medicaments are…

USPTO Abstract

A medicated module (4) for an injection system to co-deliver at least two medicaments is disclosed where a primary delivery device (7) containing a primary medicament accepts a medicated module (4) containing a single dose of a second medicament (2) and where both medicaments are delivered through a single hollow needle (3).The medicated module (4) contains a time lock feature to prevent further use after a predetermined time elapses. The medicated module (4) can also contain a rotary valve (19) operably connected to a retractable needle shield (16) that locks after a predetermined time elapses.

Drugs covered by this patent

Patent Metadata

Patent number
AU2011212561B2
Jurisdiction
AU
Classification
Expires
2014-11-20
Drug substance claim
No
Drug product claim
No
Assignee
Sanofi Aventis Deutschland GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.